Trump Secures Pharma Price Reduction

President Trump has announced an agreement with nine major pharmaceutical companies, including AbbVie, aimed at reducing drug costs. This deal is part of the administration's efforts to implement the Most Favored Nation (MFN) rule, which seeks to lower prescription prices by tying them to prices paid in other countries. The agreement is expected to have a significant impact on healthcare costs in the United States.